| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/07/2002 | US20020015708 Infectious bursal disease virus (IBDV); viral proteins transgenically expressed in plant cells or viral protein coding sequences cloned into an E. Coli expression system administered to poultry |
| 02/07/2002 | US20020015707 Combination of a viricide, an immunostimulant to induce a cell differentiation-4 antigen and a vaccine to increase cytotoxic t-cell lymphocytes |
| 02/07/2002 | US20020015706 Vaccine conjugate for producing active immunity in a bird administered in ovo; live bacteria or protozoa with a neutralizing antibody or antibody fragment bound to it |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |
| 02/07/2002 | US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody |
| 02/07/2002 | US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments |
| 02/07/2002 | US20020015693 Inducing an immune response to a T-cell independent antigen in a host, comprises administering to the host cell an interleukin-12 and T-cell independent antigen such as a carbohydrate, a lipid, a glycolipid and a carrier conjugate |
| 02/07/2002 | US20020015679 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/07/2002 | US20020014242 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 02/07/2002 | DE10036017A1 Immunostimulation by administration of purple cornflower preparation, using rectal syringe for direct injection into the lower intestines |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | CA2425037A1 Vaccines comprising outer membrane vesciles from gram negative bacteria |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2418036A1 Innate immune system-directed vaccines |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417719A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
| 02/07/2002 | CA2417671A1 Trp8, trp9 and trp10, novel markers for cancer |
| 02/07/2002 | CA2417574A1 Modified sialic acid vaccines |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417482A1 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae |
| 02/07/2002 | CA2417364A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417340A1 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | CA2417274A1 Respiratory syncytial virus vaccines |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417087A1 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416137A1 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | CA2415647A1 Neospora caninum isolate |
| 02/07/2002 | CA2415473A1 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | CA2406311A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178111A1 Vaccination against host cell-associated herpesviruses |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177288A1 Tumour-associated antigen |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177213A1 Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| 02/06/2002 | EP1177212A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
| 02/06/2002 | EP1177210A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus |
| 02/06/2002 | EP1177203A1 Collagen-binding proteins from enterococcal bacteria |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP1176979A1 High concentration immunoglobulin preparation and method for its production |
| 02/06/2002 | EP1176978A2 Hiv immunogenic compositions and methods |
| 02/06/2002 | EP1176966A2 Oligodeoxynucleotide and its use to induce an immune response |
| 02/06/2002 | EP1176957A1 Method for treating abnormal cell proliferation in the brain |
| 02/06/2002 | EP1021200B1 Methods and compositions for treating rheumatoid arthritis |
| 02/06/2002 | EP0941478B1 Assay method for peptide specific t-cells |
| 02/06/2002 | EP0815868B1 A chinese drug composition for treatment of peptic ulcer |
| 02/06/2002 | EP0672156B1 Bovine heat shock promoter and uses thereof |
| 02/06/2002 | EP0547163B1 Protein polyligands joined to a stable protein core |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334821A Humanized antibodies to gamma-interferon |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334343A Antibody for suppressing tumor growth, its derivative and its application |
| 02/06/2002 | CN1334123A Process for preparing freeze dried hepatitis A vaccine |
| 02/05/2002 | US6344554 Polynucleotide sequences from Candida albicans encoding polypeptides associated with filamentous growth |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344540 An isolated transcriptional activator polypeptide; screening antibiotics; therapy for staphyloccal infections |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344438 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 02/05/2002 | US6344354 Influenza virus replicated in mammalian cell culture and vaccine production |
| 02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344219 Oils of chenopodium ambrosiodes and adina pilulifera that inhibit pyloric spirillum |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | US6344202 Nucleotide sequence encodes major outer membrane proteins, generates antibodies that react with promoter sequence for expression in the host; drugs, vaccines |
| 02/05/2002 | US6344201 Inhibitors of e. coli and shigella enterotoxins; used for drugs and dna vaccines |
| 02/05/2002 | US6344200 Lactoferrin receptor protein |
| 02/05/2002 | US6344198 Polynucleotides used as diagnostic marker for prostate cancer and metastasis |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 02/05/2002 | CA2057612C Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 02/05/2002 | CA2016521C Fibronectin binding protein as well as its preparation |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008765A2 Basal cell markers in breast cancer and uses thereof |
| 01/31/2002 | WO2002008436A2 Mini-adenoviral vector system for vaccination |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | WO2002008426A2 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | WO2002008418A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/31/2002 | WO2002008393A2 Serine protease from yersinia enterocolitica |
| 01/31/2002 | WO2002008390A2 Bovine wasting syndrome vaccine |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |